Stage-Dependent Biomarker Changes in Spinocerebellar Ataxia Type 3

Filiaciones

Faber J:

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany

Department of Neurology, University Hospital Bonn, Bonn, Germany

Wilke C:

German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany

Hubener-Schmid J:

Institute for Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany

Schaprian T:

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany

Santana MM:

Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal

Center for Innovative in Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal

Grobe-Einsler M:

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany

Department of Neurology, University Hospital Bonn, Bonn, Germany

Onder D:

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany

Department of Neurology, University Hospital Bonn, Bonn, Germany

Koyak B:

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany

Department of Neurology, University Hospital Bonn, Bonn, Germany

Giunti P:

Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK

Department of Neurogenetics, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, WC1N 3BG, UK

Garcia-Moreno H:

Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK

Department of Neurogenetics, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, WC1N 3BG, UK

Gonzalez-Robles C:

Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK

Department of Neurogenetics, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, WC1N 3BG, UK

Lima M:

Faculdade de Ciências e Tecnologia, Universidade dos Açores, Ponta Delgada, Portugal

Raposo M:

Faculdade de Ciências e Tecnologia, Universidade dos Açores, Ponta Delgada, Portugal

Instituto de Biologia Molecular e Celular (IBMC), Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, Porto, Portugal

Melo ARV:

Faculdade de Ciências e Tecnologia, Universidade dos Açores, Ponta Delgada, Portugal

Pereira de Almeida L:

Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal

Center for Innovative in Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal

Silva P:

Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal

Center for Innovative in Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal

Faculty of Pharmacy, University of Coimbra, Azinhaga de Santa Comba, 3000-548, Coimbra, Portugal

Pinto MM:

Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal

Center for Innovative in Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal

Faculty of Pharmacy, University of Coimbra, Azinhaga de Santa Comba, 3000-548, Coimbra, Portugal

Oz G:

Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, Minnesota, USA

Joers JM:

Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, Minnesota, USA

Synofzik M:

Division Translational Genomics of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research & Center of Neurology, University of Tübingen, Germany

German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany

Schols L:

Division Translational Genomics of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research & Center of Neurology, University of Tübingen, Germany

German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany

Riess O:

Institute for Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany

Infante J:

Instituto de Investigación. University Hospital Marques de Valdecilla-IDIVAL, Santander, Spain

Centro de investigación biomédica en red de enfermedades neurodegenerativas (CIBERNED), Universidad de Cantabria, Santander, Spain

Manrique L:

Instituto de Investigación. University Hospital Marques de Valdecilla-IDIVAL, Santander, Spain

Jacobi H:

Department of Neurology, University Hospital of Heidelberg, Germany

Reetz K:

Department of Neurology, RWTH Aachen University, Pauwelsstr. 30, 52074, Aachen, Germany

JARA-BRAIN Institute Molecular Neuroscience and Neuroimaging, Research Centre Juelich GmbH and RWTH Aachen University, 52074, Aachen, Germany

Dogan I:

Department of Neurology, RWTH Aachen University, Pauwelsstr. 30, 52074, Aachen, Germany

JARA-BRAIN Institute Molecular Neuroscience and Neuroimaging, Research Centre Juelich GmbH and RWTH Aachen University, 52074, Aachen, Germany

Onyike C:

Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Povazan M:

Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205, USA

Ratai EM:

Massachusetts General Hospital, Department of Radiology, A. A. Martinos Center for Biomedical Imaging and Harvard Medical School, Charlestown, MA, USA

Schmid M:

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany

Klockgether T:

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany

Department of Neurology, University Hospital Bonn, Bonn, Germany